相关实验视频

Updated: Jan 7, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

在三年内,使用Mitomycin C的Preserflo MicroShunt治疗乌维性玻璃眼的结果

Clarissa Ern Hui Fang¹, Ameer Ali, Pinky May

¹Department of Ophthalmology, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Indian journal of ophthalmology

|December 29, 2025

概括

Preserflo MicroShunt手术有效降低眼内压力 (IOP) 在患有紫外野结核的患者. 这种手术在三年内显著降低了内脏压力和减少了药物使用,提供了成功的治疗选择.

科学领域:

眼科医生眼科眼科
青光眼研究研究研究
手术创新在外科创新.

背景情况:

在眼内压力 (IOP) 管理方面,乌维特性玻璃眼 (Uveitic glaucoma) 是一个重大挑战.
在这种患者群体中,标准治疗可能具有有限的疗效或显著的副作用.

研究的目的:

为了评估Preserflo MicroShunt手术在被诊断为患有未经控制的紫外线绿内障的患者中的疗效和结果.
在这个特定的队列中评估Preserflo MicroShunt的长期IOP控制和安全概况.

主要方法:

追溯队列研究,包括连续患有未经控制的紫外线性玻璃眼的患者.
在Preserflo MicroShunt手术中,使用了线粒素C (MMC).
收集的数据包括手术前和手术后的IOP,药物使用,视力敏度和至少2年的不良事件.

主要成果:

手术后1,2年和3年,从基线 (29 ± 8 mmHg) 显著降低了平均内血压 (12.5 ± 5.0,11.4 ± 4.8,和13.6 ± 6.8 mmHg,分别).
平均光眼的药物使用量从手术前的3.2±1.3下降到手术后的0.4-0.6.
在最后一次随访时,总体成功率 (IOP ≤21 mmHg与≥20%的降低) 为75%,报告的不良事件包括低血压和需要修改或进一步手术.

结论:

Preserflo MicroShunt手术在患有未经控制的紫外线性玻璃眼的患者中提供有效的IOP控制.
该程序显示出良好的安全性和持续有效性,直至手术后三年.

关键词:

眼内压力眼内压力保存花的微型狩猎紫外线性眼光病 (Uveitic Glaucoma) 是一种疾病.

更多相关视频

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...